In addition, the induction of FGFBP1 in a transgenic mouse model resulted in sustained hypertension and increased vascular sensitivity to the vasoconstrictor angiotensin II (Ang II) via ROS and MAP kinase pathway signaling [23,32]. The gene discussed is FGFBP1; the disease is hypertensive disorder.